With Abdullah's knowledge about genetics and it's influence on the way people respond to drugs, he and Flo set out to make genetic information more accessible. This led to the development of a new service that integrates genetic insights into medical practice. The project later received the approval and funding from NHS England, through one of it's innovation adoption arms (the West Midlands Academic Health Science Network). What started as a push to improve healthcare for a family member has turned into the Rightangled's goal to shake up the traditional healthcare system.

Over the next 4 years, Rightangled focused on developing innovative home testing technologies that could inform more accurate and individualised treatment plans. The company grew rapidly, establishing itself as a leader in home-based healthcare solutions, expanding their services to cater to a broader range of medical conditions and patient needs.

In 2023, Rightangled entered a transformative phase, becoming part of the Sibie Group. This new alliance enabled Rightangled to partner with Wegoss Online Pharmacy, one of Sibie’s subsidiary companies. Together, they began to dispense prescriptions directly to patients, streamlining the process from genetic testing to treatment delivery. This partnership marked a significant milestone, enhancing the integration of personalised medicine into everyday healthcare.